PTGS2 and breast cancer: Overall, our current study showed the presence of HPV16 E6 DNA in collected clinical biopsy sections from breast cancers (28%), and the HPV16 E6 promoted the proliferation of breast cancer via activating NF-κB signaling pathway and upregulated the expression of COX-2.